Global Anti-infective Agents Market Size To Exceed USD 159.35 Billion By 2035 | CAGR of 1.54%
Category: HealthcareGlobal Anti-infective Agents Market Size To Exceed USD 159.35 Billion By 2035
According to a Research Report Published by Spherical Insights & Consulting, the Global Anti-infective Agents Market Size is Expected to Grow from USD 134.72 Billion in 2024 to USD 159.35 Billion by 2035, at a CAGR of 1.54% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 178 pages with 124 Market data tables and figures & charts from the report on the “Global Anti-infective Agents Market Size, Share, and COVID-19 Impact Analysis, By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic, and Others), By Route Of Administration (Oral, Parenteral, Topical, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/anti-infective-agents-market
The Anti-Infective Agents Market Size encompasses a group of drugs that prevent muscles from contracting. These drugs aid in promoting smooth muscle relaxation, especially in the gastrointestinal tract. Antispasmodic medications generally treat symptoms like stomach pain and cramping. They are most commonly used to treat irritable bowel syndrome symptoms. The market growth is driven by the prevalence of infectious diseases and the rising awareness of global health issues. Government support, healthcare spending, and public-private partnerships are all speeding up R&D efforts. The COVID-19 pandemic acted as a catalyst, speeding up the approval of medications and encouraging innovation. The ongoing facilitation of pathogen spread by urbanization, international travel, and climate change also raises demand. However, the market growth is hindered by workforce shortages and more side effects.
The antiviral segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the type, the anti-infective agents market is classified into antibacterial, antiviral, antifungal & antiparasitic, and others. Among these, the antiviral segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to the increase in viral infections globally, particularly the advent of new strains and pandemics, which has led to a notable expansion in this industry. Antiviral medication demand is increasing as a result, and novel therapeutic uses are being developed.
The oral segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the route of administration, the anti-infective agents market is divided into oral, parenteral, topical, and others. Among these, the oral segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The growth is driven by their extensive effectiveness. Products like fluconazole and ibrexafungerp offer straightforward, targeted therapeutic substitutes. Their use is, however, restricted by specific drug interactions. Continuous innovation and a strong product pipeline are driving developments in this sector.
The hospital pharmacies segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the distribution channel, the anti-infective agents market is classified into hospital pharmacies, retail pharmacies, and others. Among these, the hospital pharmacies segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth can be attributed to the global rise in hospital admissions. Hospitals are preferred by patients because they offer comprehensive medical care, prompt payment, and beneficial insurance coverage. Hospital pharmacies are typically found at large medical institutions with state-of-the-art medical amenities, such as critical care units or infectious disease departments, where patients with dangerous infections are treated.
North America is anticipated to hold the largest share of the anti-infective agents market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the anti-infective agents market over the predicted timeframe. The regional growth can be attributed to the contemporary healthcare system and growing consciousness among medical professionals. Strong government initiatives to raise public health awareness, support immunization programs, encourage infection prevention, and promote the responsible use of antibiotics. Additionally, favorable reimbursement policies and strong purchasing power for expensive medications are expected to propel the market.
Asia Pacific is expected to grow at a rapid CAGR in the anti-infective agents market during the forecast period. The region's growth is being driven by the infectious diseases are becoming more common, and major market players are investing heavily in research and development. Businesses are working hard to develop new antibiotics and antivirals to combat resistant infections. Strategic alliances like the Eisai-Sato collaboration for fosravuconazole highlight this inventive propensity. These measures are expected to accelerate market expansion and expand treatment options.
Major vendors in the global anti-infective agents market are Pfizer Inc., Boehringer Ingelheim, Merck & Co., Inc., B. Braun SE, Gilead Sciences, Inc., Mankind Pharma, AbbVie, Xellia Pharmaceuticals, Bristol-Myers Squibb, Bayer AG, AstraZeneca, Sandoz International GmbH, Sanofi, Novartis AG, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Recent Development
- In January 2024, Basilea Pharmaceutical announced the acquisition of a preclinical antibiotics program from Spexis AG. The initiative targets multidrug-resistant Gram-negative bacteria using new antibiotics that inhibit lipopolysaccharide transport, a critical pathway for bacterial survival. In both in vitro and in vivo experiments, this innovative method has shown potential bactericidal effectiveness against resistant bacteria such as E. coli and K. pneumoniae.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the anti-infective agents market based on the below-mentioned segments:
Global Anti-infective Agents Market, By Type
- Antibacterial
- Antiviral
- Antifungal & Antiparasitic
- Others
Global Anti-infective Agents Market, By Route Of Administration
- Oral
- Parenteral
- Topical
- Others
Global Anti-infective Agents Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Anti-infective Agents Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?